Genotypic and phenotypic stability of Helicobacter pylori markers in a nine-year follow-up study of patients with noneradicated infection.
The cagA gene, alleles of the vacA gene,random amplified polymorphic DNA (RAPD), and neutrophil activating capacity (HpNAC) were used to examine paired H. pylori isolates from 10 noneradicated individuals 9 years apart. Paired isolates from each patient were indistinguishable with regard to vacA alleles, RAPD, and HpNAC. Isolates from nine patients showed concordance for the cagA gene, which was not detected in the recent isolate of the tenth patient. Antibodies to CagA were, however, demonstrated in the serum specimens 9 years apart and were also present in two other patients whose paired isolates were cagA-, indicating the existence of both cagA+ and cagA-organisms, with the latter predominating in some patients. The present study suggests a greater stability of phenotypic and genotypic markers of H. pylori than previously regarded. This might be true for a community with low infection and transmission rates. Complementary techniques like microarrays might, however, disclose evolutionary changes not identified here.
Gustavsson
Anders
A
Department of Medicine, Division of Gastroenterology, Orebro University Hospital, Orebro, Sweden.
Unemo
Magnus
M
Blomberg
Björn
B
Danielsson
Dan
D
D000328:Adult; D000942:Antigens, Bacterial / Q000032:analysis; D001426:Bacterial Proteins; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D005798:Genes, Bacterial; D005838:Genotype; D016481:Helicobacter Infections / Q000382:microbiology*; D016480:Helicobacter pylori / Q000235:genetics*; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D008163:Luminescent Measurements; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D019105:Random Amplified Polymorphic DNA Technique; D013270:Stomach / Q000382:microbiology
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; C074689:VacA protein, Helicobacter pylori; C080866:cagA protein, Helicobacter pylori; C092412:neutrophil-activating protein A, Helicobacter pylori
Helicobacter. 1998 Jun;3(2):79-85
9631304
J Clin Microbiol. 1999 Mar;37(3):772-4
9986850
Scand J Gastroenterol. 1996 Jul;31(7):639-42
8819210
J Infect Dis. 2000 Jan;181(1):273-82
10608776
J Infect Dis. 1990 Apr;161(4):626-33
2181029
Lancet. 1991 Aug 10;338(8763):332-5
1677696
J Med Microbiol. 1993 Nov;39(5):338-44
8246250
Scand J Infect Dis. 1995;27(4):347-50
8658068
J Clin Microbiol. 1999 Dec;37(12):4071-80
10565934
Res Microbiol. 1996 Oct;147(8):661-9
9157493
Trends Microbiol. 1999 Dec;7(12):488-93
10603484
Scand J Gastroenterol. 1994 Feb;29(2):128-32
8171279
J Clin Microbiol. 1992 Jan;30(1):192-200
1734052
Infect Immun. 1995 Jan;63(1):94-8
7806390
Lancet. 1992 Mar 21;339(8795):745-6
1347613
Dig Dis Sci. 1999 Jan;44(1):102-7
9952230
Microbes Infect. 2003 Jul;5(8):715-21
12814772
Aliment Pharmacol Ther. 1995;9 Suppl 2:33-9
8547526
J Infect Dis. 2000 Dec;182(6):1749-55
11069248
Infect Immun. 1995 Jun;63(6):2213-20
7768601
Science. 2002 Jul 26;297(5581):573-8
12142529
Gut. 1998 Jun;42(6):772-8
9691913
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53
8962108
Gut. 1993 May;34(5):599-603
8504958
J Clin Pathol. 2000 Apr;53(4):318-21
10823130
J Clin Microbiol. 1999 Sep;37(9):2979-82
10449485
N Engl J Med. 1991 Oct 17;325(16):1127-31
1891020
Lancet. 1996 Nov 30;348(9040):1462-3
8942769
J Biol Chem. 1995 Jul 28;270(30):17771-7
7629077